LORILEE SANTIAGO-PLATO: Open Payments
NPI 1861749533 · TARPON SPGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,466 in 51 payments from 10 companies in 2025. Trend: 2023 $100 · 2024 $545 · 2025 $1,466
Food & beverage: $1,466
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 14 | $464 |
| ABBVIE INC. | 16 | $390 |
| Janssen Biotech, Inc. | 2 | $167 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $116 |
| Gilead Sciences, Inc. | 3 | $80 |
| Ardelyx, Inc. | 3 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $74 |
| PFIZER INC. | 2 | $50 |
| Boston Scientific Corporation | 1 | $31 |
| Lilly USA, LLC | 1 | $21 |
Products named: REZDIFFRA, SKYRIZI, RINVOQ, TREMFYA, XIFAXAN, IBSRELA, VELSIPITY, ENTYVIO.
Industry payments across FL — which companies pay providers there.
